Cargando…

Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies

Muscular dystrophies and inflammatory myopathies are heterogeneous muscular disorders characterized by progressive muscle weakness and mass loss. Despite the high variability of etiology, inflammation and involvement of both innate and adaptive immune response are shared features. The best understoo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farini, Andrea, Villa, Chiara, Tripodi, Luana, Legato, Mariella, Torrente, Yvan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316973/ https://www.ncbi.nlm.nih.gov/pubmed/34335568 http://dx.doi.org/10.3389/fimmu.2021.666879

Ejemplares similares

The Immune System in Duchenne Muscular Dystrophy Pathogenesis
por: Tripodi, Luana, et al.
Publicado: (2021)

Role of Insulin-Like Growth Factor Receptor 2 across Muscle Homeostasis: Implications for Treating Muscular Dystrophy
por: Torrente, Yvan, et al.
Publicado: (2020)

Flavonoids and Omega3 Prevent Muscle and Cardiac Damage in Duchenne Muscular Dystrophy Animal Model
por: Tripodi, Luana, et al.
Publicado: (2021)

PTX3 Predicts Myocardial Damage and Fibrosis in Duchenne Muscular Dystrophy
por: Farini, Andrea, et al.
Publicado: (2020)

Defective dystrophic thymus determines degenerative changes in skeletal muscle
por: Farini, Andrea, et al.
Publicado: (2021)

Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy
por: Bella, Pamela, et al.
Publicado: (2019)

Influence of Immune Responses in Gene/Stem Cell Therapies for Muscular Dystrophies
por: Farini, Andrea, et al.
Publicado: (2014)

Preliminary Evidences of Safety and Efficacy of Flavonoids- and Omega 3-Based Compound for Muscular Dystrophies Treatment: A Randomized Double-Blind Placebo Controlled Pilot Clinical Trial
por: Sitzia, Clementina, et al.
Publicado: (2019)

Correlation of Circulating CD133+ Progenitor Subclasses with a Mild Phenotype in Duchenne Muscular Dystrophy Patients
por: Marchesi, Chiara, et al.
Publicado: (2008)

Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases
por: Mistretta, Miriam, et al.
Publicado: (2023)

Immunoproteasome Inhibition Ameliorates Aged Dystrophic Mouse Muscle Environment
por: Tripodi, Luana, et al.
Publicado: (2022)

Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy
por: Lerario, Alberto, et al.
Publicado: (2010)

The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies
por: Becker, Nicole, et al.
Publicado: (2022)

Oculopharyngeal muscular dystrophy or oculopharyngeal distal myopathy: case report()
por: Maeda, Marilia Yuri, et al.
Publicado: (2015)

Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T>C.
por: Rovina, Davide, et al.
Publicado: (2020)

Limb girdle muscular dystrophy type 2B masquerading as inflammatory myopathy: case report
por: Jethwa, Hannah, et al.
Publicado: (2013)

Duchenne muscular dystrophy caused by a frame-shift mutation in the acceptor splice site of intron 26
por: Meregalli, Mirella, et al.
Publicado: (2016)

Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy
por: Mohassel, Payam, et al.
Publicado: (2018)

Defining and identifying satellite cell-opathies within muscular dystrophies and myopathies
por: Ganassi, Massimo, et al.
Publicado: (2022)

Chimeric cells of maternal origin do not appear to be pathogenic in the juvenile idiopathic inflammatory myopathies or muscular dystrophy
por: Artlett, Carol M., et al.
Publicado: (2015)

Limb girdle muscular dystrophy type 2L presenting as necrotizing myopathy
por: SCHNEIDER, ILKA, et al.
Publicado: (2014)

Rimmed Vacuoles in Becker Muscular Dystrophy Have Similar Features with Inclusion Myopathies
por: Momma, Kazunari, et al.
Publicado: (2012)

Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies
por: Arvanitidis, A., et al.
Publicado: (2016)

Inflammatory myopathies and beyond: The dual role of neutrophils in muscle damage and regeneration
por: Torres-Ruiz, Jiram, et al.
Publicado: (2023)

Advancements in stem cells treatment of skeletal muscle wasting
por: Meregalli, Mirella, et al.
Publicado: (2014)

A Muscle Biosignature Differentiating Between Limb-Girdle Muscular Dystrophy and Idiopathic Inflammatory Myopathy on Magnetic Resonance Imaging
por: Hsu, Wen-Chi, et al.
Publicado: (2021)

Supplementation with a selective amino acid formula ameliorates muscular dystrophy in mdx mice
por: Banfi, Stefania, et al.
Publicado: (2018)

Becker Muscular Dystrophy-Like Myopathy Regarded as So-Called “Fatty Muscular Dystrophy” in a Pig: A Case Report and Its Diagnostic Method
por: HORIUCHI, Noriyuki, et al.
Publicado: (2013)

Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia
por: Duddy, William, et al.
Publicado: (2015)

Nutritional Status Evaluation in Patients Affected by Bethlem Myopathy and Ullrich Congenital Muscular Dystrophy
por: Toni, Silvia, et al.
Publicado: (2014)

A first-line diagnostic assay for limb-girdle muscular dystrophy and other myopathies
por: Monies, Dorota, et al.
Publicado: (2016)

Intranuclear inclusions in muscle biopsy can differentiate oculopharyngodistal myopathy and oculopharyngeal muscular dystrophy
por: Ogasawara, Masashi, et al.
Publicado: (2022)

Predictors of cardiac involvement in idiopathic inflammatory myopathies
por: Bandeira, Matilde, et al.
Publicado: (2023)

Idiopathic inflammatory myopathy and non-coding RNA
por: Yang, Yang, et al.
Publicado: (2023)

Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy
por: Godi, Claudia, et al.
Publicado: (2016)

Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin‐deficient mice
por: Farini, Andrea, et al.
Publicado: (2022)

Trained immunity as a potential target for therapeutic immunomodulation in Duchenne muscular dystrophy
por: Petrof, Basil J., et al.
Publicado: (2023)

Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role?
por: Corona-Sanchez, Esther Guadalupe, et al.
Publicado: (2022)

Clinical Applications of Mesenchymal Stem Cells in Chronic Diseases
por: Farini, Andrea, et al.
Publicado: (2014)

Overexpression of miR-29 Leads to Myopathy that Resemble Pathology of Ullrich Congenital Muscular Dystrophy
por: Liu, Chuncheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b8t3v6va8clpcjc0u60ls9nnrg